Section II
5501 – 5510 of 8748
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
The sGC stimulator BAY 41-8543 totally reverse hypoxia induced pulmonary hypertension
(
- Contribution to journal › Published meeting abstract
-
Mark
Disassociated relation between plasma tumor necrosis factor-alpha, interleukin-6 and increased body weight in Amerindian women: A long-term prospective study of natural body weight variation and impaired glucose tolerance
(
- Contribution to journal › Article
-
Mark
Characterization of the Calcitonin Gene-Related Peptide Receptor Antagonist Telcagepant (MK-0974) in Human Isolated Coronary Arteries
(
- Contribution to journal › Article
-
Mark
Emergency medicine in Scandinavia - an outstanding opportunity for research
(
- Contribution to journal › Letter
-
Mark
Validity and reliability of a Swedish version of the Relationship Assessment Scale (RAS): a pilot study
(
- Contribution to journal › Article
-
Mark
After 6 years with Xolair; a 3-year withdrawal follow-up
(
- Contribution to journal › Article
-
Mark
Overexpression of Foxf2 in adipose tissue is associated with lower levels of IRS1 and decreased glucose uptake in vivo
(
- Contribution to journal › Article
-
Mark
New Intraoperative Techniques to Improve Advanced Aortic Root Surgery
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Cardiac arrest and therapeutic hypothermia: Prognosis and outcome
(
- Thesis › Doctoral thesis (compilation)
-
Mark
MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function
(
- Contribution to journal › Article